CFMS - Conformis, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Conformis, Inc.

600 Technology Park Drive
Billerica, MA 01821
United States
781-345-9001
http://www.conformis.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees262

Key Executives

NameTitlePayExercisedYear Born
Mr. Mark A. AugustiCEO, Pres & Director770.08kN/A1966
Mr. Paul S. Weiner CPAConsultant418.3kN/A1964
Mr. Frederick W. DriscollInterim Chief Financial OfficerN/AN/A1951
Mr. Ed KilgallenVP of OperationsN/AN/AN/A
Ms. Erin HenryInterim Principal Accounting Officer & Corp. ControllerN/AN/A1984
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.

Corporate Governance

Conformis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.